Photo of Earl Blumenauer
D United States House · District 3 · Former member · Oregon

Rep. Earl Blumenauer

Compare
Total votes
2,168
all sessions
Attendance
93%
141 missed
Lower than 93% of chamber peers
With party
97%
of cast votes
Near the chamber average
Bipartisan score
1%
crosses aisle rarely
Near the chamber average
Sponsored
1,643
bills & resolutions
Higher than 86% of chamber peers
Committees
0
assignments
1,643 bills and resolutions

Sponsored bills

Total
1,643
Primary
94
Co-sponsor
1,549
This page
1,643
matching current filters
Co-sponsor HR 4449
In committee · United States House · Co-sponsor
Pathways to Health Careers Act

Pathways to Health Careers Act This bill provides funding for, reauthorizes through FY2026, and makes a variety of changes to certain grants administered by the Department of Health and Human Services that provide education and training to low-income individuals for health care occupations, including by establishing a new competitive grant for projects designed to train low-income individuals in allied health professions.

In committee Jul 16, 2021 1 co-sponsor
Co-sponsor HR 925
In committee · United States House · Co-sponsor
Data to Save Moms Act

Data to Save Moms Act This bill expands data collection and research on maternal morbidity and mortality among minority populations. Specifically, the bill adds requirements to a program within the Centers for Disease Control and Prevention (CDC) that supports maternal mortality review committees. To the extent practicable, the committees must use the most up-to-date indicators of severe maternal morbidity; review deaths caused by suicide, overdose, or other behavioral health conditions attributed to or aggravated by pregnancy or childbirth; and consult with representatives of communities about nonclinical factors that may contribute to adverse maternal outcomes. The CDC may also award grants to committees to increase their engagement with local communities, such as by bringing on community representatives as committee members. Additionally, the Centers for Medicare & Medicaid Services and the Agency for Healthcare Research and Quality must consult with diverse stakeholders to review maternal health data collection processes and quality measures and make recommendations to improve them. The Indian Health Service and the Department of Health and Human Services must also arrange for studies on adverse maternal health outcomes among tribal and minority populations, respectively.

In committee Jul 15, 2021 1 co-sponsor
Co-sponsor HR 2816
In committee · United States House · Co-sponsor
Legacy Roads and Trails Act

Legacy Roads and Trails Act This bill directs the Department of Agriculture (USDA) to establish the Forest Service Legacy Roads and Trails Remediation Program. Specifically, under the program, the Forest Service, taking into account predicted changes in weather and hydrology related to global climate change, shall carry out storm damage risk reduction, including deferred maintenance, repairs, road and trail relocation, and associated activities on roads, trails, tunnels, and bridges under the jurisdiction of the Forest Service; restore waterways and natural migration of fish and other aquatic species by removing or replacing culverts or other infrastructure from such waterways; and decommission unneeded roads. In implementing the program, the Forest Service shall give priority to projects that protect or restore water quality and watershed function; a watershed that supplies a public drinking water system; the habitat of a threatened, endangered, or sensitive fish or wildlife species, or a species of conservation concern; or a watershed for which the Forest Service has completed a watershed protection and restoration action plan. The Forest Service shall identify the minimum road system needed for each unit of the National Forest System. USDA shall review, and may revise, an identification of the minimum road system in accordance with federal regulations relating to the administration of the forest transportation system.

In committee Jul 13, 2021 1 co-sponsor
Co-sponsor HR 4386
In committee · United States House · Co-sponsor
Assuring Regular Consultation to Have Indigenous Voices Effectively Solicited Act

Assuring Regular Consultation to Have Indigenous Voices Effectively Solicited Act This bill establishes requirements for tribal consultation prior to the sale or transfer of certain federal civilian real property. Federal civilian real property generally refers to federal real property assets, including public buildings, occupied and improved grounds, leased space, or other physical structures under the custody and control of a federal agency. Specifically, a federal agency must consult with tribal governments prior to the sale or transfer of certain federal civilian real property if the proposed sale or transfer would affect a tribe's access to federal agency services. Further, the bill prohibits the property from being sold or transferred if the sale or transfer would substantially reduce or eliminate a tribe's access to these services.

In committee Jul 12, 2021 1 co-sponsor
Co-sponsor HR 4390
In committee · United States House · Co-sponsor
PROTECT 340B Act of 2021

Preserving Rules Ordered for The Entities Covered Through 340B Act of 2021 or the PROTECT 340B Act of 2021 This bill prohibits pharmacy benefit managers (PBMs) and health insurance plans from discriminating against health providers participating in the 340B drug pricing program, including pharmacies contracted with such providers to dispense 340B drugs. The 340B program allows certain providers to receive covered outpatient drugs at reduced prices from manufacturers. Specifically, PBMs and insurance plans may not reimburse 340B participants at a lower rate than other entities not participating in the program; impose differing terms (such as fees, charge-backs, or audits) on 340B participants; interfere with an individual's choice to receive drugs from a 340B participant; require 340B participants to identify which drugs fall within the program; or refuse to contract with a 340B participant on the basis that they utilize the program. Violations of this bill are subject to a civil penalty of not more than $5,000 per violation per day. These prohibitions also apply to prescription drug (Part D) sponsors under Medicare. The bill also provides for a process to prevent duplicate 340B drug discounts to states under Medicaid.

In committee Jul 12, 2021 1 co-sponsor
Co-sponsor HR 1443
Passed · United States House · Co-sponsor
LGBTQ Business Equal Credit Enforcement and Investment Act

LGBTQ Business Equal Credit Enforcement and Investment Act This bill requires financial institutions to report certain credit application data to the Consumer Financial Protection Bureau for the purposes of enforcing fair lending laws. Specifically, financial institutions must report this data regarding lesbian-, gay-, bisexual-, transgender-, or queer-owned businesses. Currently, this data is reported regarding women-owned, minority-owned, and small businesses.

Passed Jul 12, 2021 1 co-sponsor
Co-sponsor HR 239
Passed · United States House · Co-sponsor
Equal Access to Contraception for Veterans Act

Equal Access to Contraception for Veterans Act This bill prohibits the Department of Veterans Affairs from requiring payment from a veteran for any contraceptive item that is required to be covered by health insurance plans without a cost-sharing requirement.

Passed Jul 12, 2021 1 co-sponsor
Co-sponsor HR 4385
In committee · United States House · Co-sponsor
Cancer Drug Parity Act of 2021

Cancer Drug Parity Act of 20 21 This bill requires group health plans that cover anticancer medications administered by a health care provider to provide no less favorable cost sharing for patient-administered anticancer medications. This requirement applies to medications that are (1) approved by the Food and Drug Administration; (2) medically necessary for the cancer treatment; and (3) clinically appropriate in terms of type, frequency, extent site, and duration. To comply with this requirement, plans may not, with respect to anticancer medications (1) change or replace benefits to increase out-of-pocket costs, (2) reclassify benefits to increase costs, or (3) apply more restrictive limitations to orally administered medications than to intravenously administered or injected medications.

In committee Jul 9, 2021 1 co-sponsor
Co-sponsor HR 4402
In committee · United States House · Co-sponsor
Safe Schools Improvement Act of 2021

Safe Schools Improvement Act of 2021 This bill requires states to direct their local educational agencies (LEAs) to establish policies that prevent and prohibit bullying and harassment of elementary and secondary school students. In particular, these policies must prohibit bullying and harassment based on race, color, national origin, sex, sexual orientation, gender identity, disability, or religion. Further, LEAs must provide (1) students, parents, and educational professionals with annual notice of the conduct prohibited in their disciplinary policies; (2) students and parents with grievance procedures that target such conduct; and (3) the public with annual data on the incidence and frequency of that conduct at the school and LEA level. The Department of Education must conduct and report on an independent biennial evaluation of programs and policies to combat bullying and harassment in elementary and secondary schools. The National Center for Education Statistics must collect state data to determine the incidence and frequency of the conduct prohibited by LEA disciplinary policies.

In committee Jul 9, 2021 1 co-sponsor
Showing 1,171 to 1,180 of 1,643 bills